HOME >> BIOLOGY >> NEWS
$7.5 Million grant to Yale researchers for role of viruses in cancer

New Haven, Conn. -- The National Cancer Institute recently awarded a five-year, $7.5 million program project grant to investigators at the Yale School of Medicine to continue studies on the role of viruses and mutant cellular proteins in tumorigenic transformation of cells.

This grant, "Program on the Molecular Basis of Viral and Cellular Transformation," is currently in its 31st year and is one of the largest and longest-running basic science grants at Yale. It coordinates studies to understand how viral genes and related cellular genes cause cells to escape normal growth controls and induce cancer.

"Because viruses are so well-defined and relatively simple compared to their host cells, we are optimistic that studies supported by this grant will continue to identify new targets for therapy and suggest new approaches to prevent and treat cancers," said principal investigator Daniel DiMaio, M.D., Waldemar Von Zedtwitz Professor of Genetics and vice chair of the Department of Genetics.

DiMaio studies human papillomaviruses (HPV), the causative agents of cervical cancer. His laboratory has shown that HPV oncogenes must be expressed continuously in cervical cancer cells for the cells to maintain their malignant characteristics, validating the viral genes as new therapeutic targets. In the current granting period, the DiMaio laboratory will continue to dissect the pathways activated when HPV oncogenes are repressed in cervical cancer cells.

Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus, two herpesviruses that are unusual in their ability
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
22-Sep-2004


Page: 1 2

Related biology news :

1. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
2. 5 Million award for pioneering project to train new breed of scientists
3. 2 Million of yeast to triple available drug treatments
4. $10 Million center for theoretical biological physics created at UCSD by NSF
5. Million dollar grant by the Paul G. Allen Foundation for Medical Research to University of Washington medical scientist program
6. $14 Million NIH grant launches heart, lung, blood and sleep disorders center at the Jackson Laboratory
7. NSF awards $4.2 Million grants to three coastal sites for long-term ecological research
8. JDF awards $10 Million to Childrens Hospital of Pittsburgh and University of Pittsburgh for new research center to help speed diabetes cure
9. AVAX Technologies receives an additional $3.0 Million (AUD) investment in Australian joint venture from Australian Vaccine Technologies Ltd.
10. Columbia University College of Physicians and Surgeons receives $2.4 Million grant from Howard Hughes Medical Institute
11. UCSF School of Medicine receives $3.8 Million grant for biomedical research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 04, 2019 , ... NDA ... Todd , a regulatory toxicology expert with more than 20 years of experience ... , Dr. Todd has extensive experience with a variety of biologic modalities ...
(Date:11/27/2019)... ... November 26, 2019 , ... Personalized Stem Cells, ... on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle ... took place on October 23, 2019, highlighted the ongoing efforts to promote research, educate ...
(Date:11/19/2019)... ... November 19, 2019 , ... Diagenode, Inc., ... Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science ... offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, to help ...
Breaking Biology News(10 mins):
(Date:12/14/2019)... (PRWEB) , ... December 12, 2019 , ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... of 2019. The new LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system ...
(Date:12/4/2019)... N.C. (PRWEB) , ... December 03, 2019 , ... A ... studies have shown can reduce and even reverse fibrosis (scar tissue) buildup – also ... at Stanford University School of Medicine, was conducted on mice. , The tumor-destroying ...
(Date:11/22/2019)... , ... November 22, 2019 ... ... engineering firm, hosted a live webinar covering a step-by-step cold chain validation ... antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, ...
(Date:11/12/2019)... (PRWEB) , ... November 12, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics ... has adopted Genedata Biologics® to streamline their R&D operations related ...
Breaking Biology Technology:
Cached News: